 |
PDBsum entry 1asu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
DNA integration
|
PDB id
|
|
|
|
1asu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.7.7.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.2.7.7.49
- RNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
E.C.3.1.26.4
- ribonuclease H.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Endonucleolytic cleavage to 5'-phosphomonoester.
|
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
E.C.3.4.23.-
- ?????
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
253:333-346
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
High-resolution structure of the catalytic domain of avian sarcoma virus integrase.
|
|
G.Bujacz,
M.Jaskólski,
J.Alexandratos,
A.Wlodawer,
G.Merkel,
R.A.Katz,
A.M.Skalka.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Retroviral integrase (IN) functions to insert retroviral DNA into the host cell
chromosome in a highly coordinated manner. IN catalyzes two biochemically
separable reactions: processing of the viral DNA ends and joining of these ends
to the host DNA. Previous studies suggested that these two reactions are
chemically similar and are carried out by a single active site that is
characterized by a highly conserved constellation of carboxylate residues, the
D,D(35)E motif. We report here the crystal structure of the isolated catalytic
domain of avian sarcoma virus (ASV) IN, solved using multiwavelength anomalous
diffraction data for a selenomethionine derivative and refined at 1.7 A
resolution. The protein is a crystallographic dimer with each monomer featuring
a five-stranded mixed beta-sheet region surrounded by five alpha-helices. Based
on the general fold and the arrangement of catalytic carboxylate residues, it is
apparent that ASV IN is a member of a superfamily of proteins that also includes
two types of nucleases, RuvC and RNase H. The general fold and the dimer
interface are similar to those of the analogous domain of HIV-1 IN, whose
crystal structure has been determined at 2.5 A resolution. However, the ASV IN
structure is more complete in that all three critical carboxylic acids, Asp64,
Asp121 and Glu157, are ordered. The ordered active site and the considerably
higher resolution of the present structure are all important to an understanding
of the mechanism of retroviral DNA integration, as well as for designing
antiviral agents that may be effective against HIV.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Primary structure of retroviral integrase. A, Representation of ASV IN showing the three functional domains
and indicating the fragment included in the domain analyzed in this investigation. B, Alignment of the amino acid
sequences in the ASV andHIV-1IN catalytic domains, with the elements of secondary structure indicated. Residues shown
in red are identical, those shown in blue are of similar type. The sequence with a broken underline was not observed in
the crystal structure of HIV-1 IN.
|
 |
Figure 5.
Figure 5. Stereoviews of the dimers of the catalytic domain of IN generated using O (Jones & Kjeldgaard, 1994). A, A
dimer of the ASV IN core domain viewed along its 2-fold axis, with Wat450 positions marked as blue spheres. B,
Superposition of the main chains of ASV and HIV-1 IN core domains. The superposition is based on the best fit between
the C
a
atoms of the blue (ASV) and gold (HIV-1) chains. The green (ASV) and red (HIV-1) subunits (generated by the
corresponding molecular dyads) show considerable deviations.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1995,
253,
333-346)
copyright 1995.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Huang,
G.H.Grant,
and
W.G.Richards
(2011).
Binding modes of diketo-acid inhibitors of HIV-1 integrase: A comparative molecular dynamics simulation study.
|
| |
J Mol Graph Model,
29,
956-964.
|
 |
|
|
|
|
 |
A.Goulet,
M.Pina,
P.Redder,
D.Prangishvili,
L.Vera,
J.Lichière,
N.Leulliot,
H.van Tilbeurgh,
M.Ortiz-Lombardia,
V.Campanacci,
and
C.Cambillau
(2010).
ORF157 from the archaeal virus Acidianus filamentous virus 1 defines a new class of nuclease.
|
| |
J Virol,
84,
5025-5031.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Craigie
(2010).
Structural biology: When four become one.
|
| |
Nature,
464,
167-168.
|
 |
|
|
|
|
 |
Z.Dauter,
M.Jaskolski,
and
A.Wlodawer
(2010).
Impact of synchrotron radiation on macromolecular crystallography: a personal view.
|
| |
J Synchrotron Radiat,
17,
433-444.
|
 |
|
|
|
|
 |
M.Jaskolski,
J.N.Alexandratos,
G.Bujacz,
and
A.Wlodawer
(2009).
Piecing together the structure of retroviral integrase, an important target in AIDS therapy.
|
| |
FEBS J,
276,
2926-2946.
|
 |
|
|
|
|
 |
S.Bera,
K.K.Pandey,
A.C.Vora,
and
D.P.Grandgenett
(2009).
Molecular Interactions between HIV-1 integrase and the two viral DNA ends within the synaptic complex that mediates concerted integration.
|
| |
J Mol Biol,
389,
183-198.
|
 |
|
|
|
|
 |
J.H.Keith,
C.A.Schaeper,
T.S.Fraser,
and
M.J.Fraser
(2008).
Mutational analysis of highly conserved aspartate residues essential to the catalytic core of the piggyBac transposase.
|
| |
BMC Mol Biol,
9,
73.
|
 |
|
|
|
|
 |
H.Chon,
T.Tadokoro,
N.Ohtani,
Y.Koga,
K.Takano,
and
S.Kanaya
(2006).
Identification of RNase HII from psychrotrophic bacterium, Shewanella sp. SIB1 as a high-activity type RNase H.
|
| |
FEBS J,
273,
2264-2275.
|
 |
|
|
|
|
 |
J.Jaganatharaja,
and
R.Gowthaman
(2006).
Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model.
|
| |
Bioinformation,
1,
112-117.
|
 |
|
|
|
|
 |
J.Puglia,
T.Wang,
C.Smith-Snyder,
M.Cote,
M.Scher,
J.N.Pelletier,
S.John,
C.B.Jonsson,
and
M.J.Roth
(2006).
Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.
|
| |
J Virol,
80,
9497-9510.
|
 |
|
|
|
|
 |
M.Li,
M.Mizuuchi,
T.R.Burke,
and
R.Craigie
(2006).
Retroviral DNA integration: reaction pathway and critical intermediates.
|
| |
EMBO J,
25,
1295-1304.
|
 |
|
|
|
|
 |
R.Tobes,
and
E.Pareja
(2006).
Bacterial repetitive extragenic palindromic sequences are DNA targets for Insertion Sequence elements.
|
| |
BMC Genomics,
7,
62.
|
 |
|
|
|
|
 |
A.Brigo,
K.W.Lee,
G.Iurcu Mustata,
and
J.M.Briggs
(2005).
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.
|
| |
Biophys J,
88,
3072-3082.
|
 |
|
|
|
|
 |
B.Ason,
D.J.Knauss,
A.M.Balke,
G.Merkel,
A.M.Skalka,
and
W.S.Reznikoff
(2005).
Targeting Tn5 transposase identifies human immunodeficiency virus type 1 inhibitors.
|
| |
Antimicrob Agents Chemother,
49,
2035-2043.
|
 |
|
|
|
|
 |
J.Snásel,
Z.Krejcík,
V.Jencová,
I.Rosenberg,
T.Ruml,
J.Alexandratos,
A.Gustchina,
and
I.Pichová
(2005).
Integrase of Mason-Pfizer monkey virus.
|
| |
FEBS J,
272,
203-216.
|
 |
|
|
|
|
 |
J.Wielens,
I.T.Crosby,
and
D.K.Chalmers
(2005).
A three-dimensional model of the human immunodeficiency virus type 1 integration complex.
|
| |
J Comput Aided Mol Des,
19,
301-317.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Li,
and
R.Craigie
(2005).
Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration.
|
| |
J Biol Chem,
280,
29334-29339.
|
 |
|
|
|
|
 |
R.G.Maroun,
L.Zargarian,
R.Stocklin,
F.Troalen,
C.K.Jankowski,
and
S.Fermandjian
(2005).
A structural study of model peptides derived from HIV-1 integrase central domain.
|
| |
Rapid Commun Mass Spectrom,
19,
2539-2548.
|
 |
|
|
|
|
 |
B.Ason,
and
W.S.Reznikoff
(2004).
A high-throughput assay for Tn5 Tnp-induced DNA cleavage.
|
| |
Nucleic Acids Res,
32,
e83.
|
 |
|
|
|
|
 |
C.Calmels,
V.R.de Soultrait,
A.Caumont,
C.Desjobert,
A.Faure,
M.Fournier,
L.Tarrago-Litvak,
and
V.Parissi
(2004).
Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.
|
| |
Nucleic Acids Res,
32,
1527-1538.
|
 |
|
|
|
|
 |
L.Tao,
and
A.L.Harris
(2004).
Biochemical requirements for inhibition of Connexin26-containing channels by natural and synthetic taurine analogs.
|
| |
J Biol Chem,
279,
38544-38554.
|
 |
|
|
|
|
 |
T.K.Au,
S.Pathania,
and
R.M.Harshey
(2004).
True reversal of Mu integration.
|
| |
EMBO J,
23,
3408-3420.
|
 |
|
|
|
|
 |
V.L.Brandt,
and
D.B.Roth
(2004).
V(D)J recombination: how to tame a transposase.
|
| |
Immunol Rev,
200,
249-260.
|
 |
|
|
|
|
 |
A.L.Harper,
M.Sudol,
and
M.Katzman
(2003).
An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.
|
| |
J Virol,
77,
3838-3845.
|
 |
|
|
|
|
 |
I.Lee,
and
R.M.Harshey
(2003).
Patterns of sequence conservation at termini of long terminal repeat (LTR) retrotransposons and DNA transposons in the human genome: lessons from phage Mu.
|
| |
Nucleic Acids Res,
31,
4531-4540.
|
 |
|
|
|
|
 |
K.K.Bao,
H.Wang,
J.K.Miller,
D.A.Erie,
A.M.Skalka,
and
I.Wong
(2003).
Functional oligomeric state of avian sarcoma virus integrase.
|
| |
J Biol Chem,
278,
1323-1327.
|
 |
|
|
|
|
 |
K.Moreau,
C.Faure,
S.Violot,
G.Verdier,
and
C.Ronfort
(2003).
Mutations in the C-terminal domain of ALSV (Avian Leukemia and Sarcoma Viruses) integrase alter the concerted DNA integration process in vitro.
|
| |
Eur J Biochem,
270,
4426-4438.
|
 |
|
|
|
|
 |
L.Zargarian,
M.S.Benleumi,
J.G.Renisio,
H.Merad,
R.G.Maroun,
F.Wieber,
O.Mauffret,
H.Porumb,
F.Troalen,
and
S.Fermandjian
(2003).
Strategy to discriminate between high and low affinity bindings of human immunodeficiency virus, type 1 integrase to viral DNA.
|
| |
J Biol Chem,
278,
19966-19973.
|
 |
|
|
|
|
 |
M.J.Curcio,
and
K.M.Derbyshire
(2003).
The outs and ins of transposition: from mu to kangaroo.
|
| |
Nat Rev Mol Cell Biol,
4,
865-877.
|
 |
|
|
|
|
 |
R.Chiu,
and
D.P.Grandgenett
(2003).
Molecular and genetic determinants of rous sarcoma virus integrase for concerted DNA integration.
|
| |
J Virol,
77,
6482-6492.
|
 |
|
|
|
|
 |
A.Krakowiak,
A.Owczarek,
M.Koziołkiewicz,
and
W.J.Stec
(2002).
Stereochemical course of Escherichia coli RNase H.
|
| |
Chembiochem,
3,
1242-1250.
|
 |
|
|
|
|
 |
E.Brin,
and
J.Leis
(2002).
Changes in the mechanism of DNA integration in vitro induced by base substitutions in the HIV-1 U5 and U3 terminal sequences.
|
| |
J Biol Chem,
277,
10938-10948.
|
 |
|
|
|
|
 |
A.Muroya,
D.Tsuchiya,
M.Ishikawa,
M.Haruki,
M.Morikawa,
S.Kanaya,
and
K.Morikawa
(2001).
Catalytic center of an archaeal type 2 ribonuclease H as revealed by X-ray crystallographic and mutational analyses.
|
| |
Protein Sci,
10,
707-714.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Laboulais,
E.Deprez,
H.Leh,
J.F.Mouscadet,
J.C.Brochon,
and
M.Le Bret
(2001).
HIV-1 integrase catalytic core: molecular dynamics and simulated fluorescence decays.
|
| |
Biophys J,
81,
473-489.
|
 |
|
|
|
|
 |
D.M.Tobiason,
J.M.Buchner,
W.H.Thiel,
K.M.Gernert,
and
A.C.Karls
(2001).
Conserved amino acid motifs from the novel Piv/MooV family of transposases and site-specific recombinases are required for catalysis of DNA inversion by Piv.
|
| |
Mol Microbiol,
39,
641-651.
|
 |
|
|
|
|
 |
F.Bertola,
C.Manigand,
P.Picard,
M.Goetz,
J.M.Schmitter,
and
G.Precigoux
(2001).
N-Terminal domain of HTLV-I integrase. Complexation and conformational studies of the zinc finger.
|
| |
J Pept Sci,
7,
588-597.
|
 |
|
|
|
|
 |
F.Yang,
and
M.J.Roth
(2001).
Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase.
|
| |
J Virol,
75,
9561-9570.
|
 |
|
|
|
|
 |
J.Y.Wang,
H.Ling,
W.Yang,
and
R.Craigie
(2001).
Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.
|
| |
EMBO J,
20,
7333-7343.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Gao,
S.L.Butler,
and
F.Bushman
(2001).
Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.
|
| |
EMBO J,
20,
3565-3576.
|
 |
|
|
|
|
 |
V.Molteni,
J.Greenwald,
D.Rhodes,
Y.Hwang,
W.Kwiatkowski,
F.D.Bushman,
J.S.Siegel,
and
S.Choe
(2001).
Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
536-544.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.R.Davies,
I.Y.Goryshin,
W.S.Reznikoff,
and
I.Rayment
(2000).
Three-dimensional structure of the Tn5 synaptic complex transposition intermediate.
|
| |
Science,
289,
77-85.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.C.Chen,
J.Krucinski,
L.J.Miercke,
J.S.Finer-Moore,
A.H.Tang,
A.D.Leavitt,
and
R.M.Stroud
(2000).
Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.
|
| |
Proc Natl Acad Sci U S A,
97,
8233-8238.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Lai,
H.Yokota,
L.W.Hung,
R.Kim,
and
S.H.Kim
(2000).
Crystal structure of archaeal RNase HII: a homologue of human major RNase H.
|
| |
Structure,
8,
897-904.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.D.Lins,
T.P.Straatsma,
and
J.M.Briggs
(2000).
Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
|
| |
Biopolymers,
53,
308-315.
|
 |
|
|
|
|
 |
S.D.Fugmann,
I.J.Villey,
L.M.Ptaszek,
and
D.G.Schatz
(2000).
Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex.
|
| |
Mol Cell,
5,
97.
|
 |
|
|
|
|
 |
A.P.Eijkelenboom,
R.Sprangers,
K.Hård,
R.A.Puras Lutzke,
R.H.Plasterk,
R.Boelens,
and
R.Kaptein
(1999).
Refined solution structure of the C-terminal DNA-binding domain of human immunovirus-1 integrase.
|
| |
Proteins,
36,
556-564.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.R.Davies,
L.Mahnke Braam,
W.S.Reznikoff,
and
I.Rayment
(1999).
The three-dimensional structure of a Tn5 transposase-related protein determined to 2.9-A resolution.
|
| |
J Biol Chem,
274,
11904-11913.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.M.van den Ent,
A.Vos,
and
R.H.Plasterk
(1999).
Dissecting the role of the N-terminal domain of human immunodeficiency virus integrase by trans-complementation analysis.
|
| |
J Virol,
73,
3176-3183.
|
 |
|
|
|
|
 |
J.Greenwald,
V.Le,
S.L.Butler,
F.D.Bushman,
and
S.Choe
(1999).
The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
|
| |
Biochemistry,
38,
8892-8898.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.L.Gerton,
D.Herschlag,
and
P.O.Brown
(1999).
Stereospecificity of reactions catalyzed by HIV-1 integrase.
|
| |
J Biol Chem,
274,
33480-33487.
|
 |
|
|
|
|
 |
L.Haren,
B.Ton-Hoang,
and
M.Chandler
(1999).
Integrating DNA: transposases and retroviral integrases.
|
| |
Annu Rev Microbiol,
53,
245-281.
|
 |
|
|
|
|
 |
M.A.Landree,
J.A.Wibbenmeyer,
and
D.B.Roth
(1999).
Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination.
|
| |
Genes Dev,
13,
3059-3069.
|
 |
|
|
|
|
 |
P.Hindmarsh,
and
J.Leis
(1999).
Retroviral DNA integration.
|
| |
Microbiol Mol Biol Rev,
63,
836.
|
 |
|
|
|
|
 |
R.D.Lins,
J.M.Briggs,
T.P.Straatsma,
H.A.Carlson,
J.Greenwald,
S.Choe,
and
J.A.McCammon
(1999).
Molecular dynamics studies on the HIV-1 integrase catalytic domain.
|
| |
Biophys J,
76,
2999-3011.
|
 |
|
|
|
|
 |
R.G.Maroun,
D.Krebs,
M.Roshani,
H.Porumb,
C.Auclair,
F.Troalen,
and
S.Fermandjian
(1999).
Conformational aspects of HIV-1 integrase inhibition by a peptide derived from the enzyme central domain and by antibodies raised against this peptide.
|
| |
Eur J Biochem,
260,
145-155.
|
 |
|
|
|
|
 |
T.L.Williams,
E.L.Jackson,
A.Carritte,
and
T.A.Baker
(1999).
Organization and dynamics of the Mu transpososome: recombination by communication between two active sites.
|
| |
Genes Dev,
13,
2725-2737.
|
 |
|
|
|
|
 |
A.E.Leschziner,
T.J.Griffin,
and
N.D.Grindley
(1998).
Tn552 transposase catalyzes concerted strand transfer in vitro.
|
| |
Proc Natl Acad Sci U S A,
95,
7345-7350.
|
 |
|
|
|
|
 |
A.Wlodawer,
and
J.Vondrasek
(1998).
Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.
|
| |
Annu Rev Biophys Biomol Struct,
27,
249-284.
|
 |
|
|
|
|
 |
E.Asante-Appiah,
S.H.Seeholzer,
and
A.M.Skalka
(1998).
Structural determinants of metal-induced conformational changes in HIV-1 integrase.
|
| |
J Biol Chem,
273,
35078-35087.
|
 |
|
|
|
|
 |
E.L.Beall,
and
D.C.Rio
(1998).
Transposase makes critical contacts with, and is stimulated by, single-stranded DNA at the P element termini in vitro.
|
| |
EMBO J,
17,
2122-2136.
|
 |
|
|
|
|
 |
F.M.van den Ent,
A.Vos,
and
R.H.Plasterk
(1998).
Mutational scan of the human immunodeficiency virus type 2 integrase protein.
|
| |
J Virol,
72,
3916-3924.
|
 |
|
|
|
|
 |
G.A.Donzella,
O.Leon,
and
M.J.Roth
(1998).
Implication of a central cysteine residue and the HHCC domain of Moloney murine leukemia virus integrase protein in functional multimerization.
|
| |
J Virol,
72,
1691-1698.
|
 |
|
|
|
|
 |
J.L.Gerton,
S.Ohgi,
M.Olsen,
J.DeRisi,
and
P.O.Brown
(1998).
Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions.
|
| |
J Virol,
72,
5046-5055.
|
 |
|
|
|
|
 |
J.L.Keck,
E.R.Goedken,
and
S.Marqusee
(1998).
Activation/attenuation model for RNase H. A one-metal mechanism with second-metal inhibition.
|
| |
J Biol Chem,
273,
34128-34133.
|
 |
|
|
|
|
 |
J.Lubkowski,
F.Yang,
J.Alexandratos,
A.Wlodawer,
H.Zhao,
T.R.Burke,
N.Neamati,
Y.Pommier,
G.Merkel,
and
A.M.Skalka
(1998).
Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.
|
| |
Proc Natl Acad Sci U S A,
95,
4831-4836.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Lubkowski,
F.Yang,
J.Alexandratos,
G.Merkel,
R.A.Katz,
K.Gravuer,
A.M.Skalka,
and
A.Wlodawer
(1998).
Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase.
|
| |
J Biol Chem,
273,
32685-32689.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.A.Mahnke Braam,
and
W.S.Reznikoff
(1998).
Functional characterization of the Tn5 transposase by limited proteolysis.
|
| |
J Biol Chem,
273,
10908-10913.
|
 |
|
|
|
|
 |
M.Katzman,
and
M.Sudol
(1998).
Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins.
|
| |
J Virol,
72,
1744-1753.
|
 |
|
|
|
|
 |
P.M.Fitzgerald,
J.K.Wu,
and
J.H.Toney
(1998).
Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution.
|
| |
Biochemistry,
37,
6791-6800.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.A.Lutzke,
and
R.H.Plasterk
(1998).
Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding.
|
| |
J Virol,
72,
4841-4848.
|
 |
|
|
|
|
 |
T.S.Heuer,
and
P.O.Brown
(1998).
Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.
|
| |
Biochemistry,
37,
6667-6678.
|
 |
|
|
|
|
 |
Y.Goldgur,
F.Dyda,
A.B.Hickman,
T.M.Jenkins,
R.Craigie,
and
D.R.Davies
(1998).
Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.
|
| |
Proc Natl Acad Sci U S A,
95,
9150-9154.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Engelman,
Y.Liu,
H.Chen,
M.Farzan,
and
F.Dyda
(1997).
Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.
|
| |
J Virol,
71,
3507-3514.
|
 |
|
|
|
|
 |
A.P.Eijkelenboom,
F.M.van den Ent,
A.Vos,
J.F.Doreleijers,
K.Hård,
T.D.Tullius,
R.H.Plasterk,
R.Kaptein,
and
R.Boelens
(1997).
The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc.
|
| |
Curr Biol,
7,
739-746.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Hazuda,
P.Felock,
J.Hastings,
B.Pramanik,
A.Wolfe,
G.Goodarzi,
A.Vora,
K.Brackmann,
and
D.Grandgenett
(1997).
Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds.
|
| |
J Virol,
71,
807-811.
|
 |
|
|
|
|
 |
G.Bujacz,
J.Alexandratos,
A.Wlodawer,
G.Merkel,
M.Andrake,
R.A.Katz,
and
A.M.Skalka
(1997).
Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity.
|
| |
J Biol Chem,
272,
18161-18168.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Kukolj,
K.S.Jones,
and
A.M.Skalka
(1997).
Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases.
|
| |
J Virol,
71,
843-847.
|
 |
|
|
|
|
 |
H.J.Kwon,
R.Tirumalai,
A.Landy,
and
T.Ellenberger
(1997).
Flexibility in DNA recombination: structure of the lambda integrase catalytic core.
|
| |
Science,
276,
126-131.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Cai,
R.Zheng,
M.Caffrey,
R.Craigie,
G.M.Clore,
and
A.M.Gronenborn
(1997).
Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.
|
| |
Nat Struct Biol,
4,
567-577.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Thomas,
and
L.Brady
(1997).
HIV integrase: a target for AIDS therapeutics.
|
| |
Trends Biotechnol,
15,
167-172.
|
 |
|
|
|
|
 |
S.Q.Wei,
K.Mizuuchi,
and
R.Craigie
(1997).
A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.
|
| |
EMBO J,
16,
7511-7520.
|
 |
|
|
|
|
 |
S.Schumacher,
R.T.Clubb,
M.Cai,
K.Mizuuchi,
G.M.Clore,
and
A.M.Gronenborn
(1997).
Solution structure of the Mu end DNA-binding ibeta subdomain of phage Mu transposase: modular DNA recognition by two tethered domains.
|
| |
EMBO J,
16,
7532-7541.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.M.Jenkins,
D.Esposito,
A.Engelman,
and
R.Craigie
(1997).
Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking.
|
| |
EMBO J,
16,
6849-6859.
|
 |
|
|
|
|
 |
T.S.Heuer,
and
P.O.Brown
(1997).
Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
|
| |
Biochemistry,
36,
10655-10665.
|
 |
|
|
|
|
 |
X.Ji,
M.Tordova,
R.O'Donnell,
J.F.Parsons,
J.B.Hayden,
G.L.Gilliland,
and
P.Zimniak
(1997).
Structure and function of the xenobiotic substrate-binding site and location of a potential non-substrate-binding site in a class pi glutathione S-transferase.
|
| |
Biochemistry,
36,
9690-9702.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Taddeo,
F.Carlini,
P.Verani,
and
A.Engelman
(1996).
Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity.
|
| |
J Virol,
70,
8277-8284.
|
 |
|
|
|
|
 |
E.V.Barsov,
W.E.Huber,
J.Marcotrigiano,
P.K.Clark,
A.D.Clark,
E.Arnold,
and
S.H.Hughes
(1996).
Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions.
|
| |
J Virol,
70,
4484-4494.
|
 |
|
|
|
|
 |
F.Sourgen,
R.G.Maroun,
V.Frère,
M.Bouziane,
C.Auclair,
F.Troalen,
and
S.Fermandjian
(1996).
A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results.
|
| |
Eur J Biochem,
240,
765-773.
|
 |
|
|
|
|
 |
G.Bujacz,
M.Jaskólski,
J.Alexandratos,
A.Wlodawer,
G.Merkel,
R.A.Katz,
and
A.M.Skalka
(1996).
The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.
|
| |
Structure,
4,
89-96.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Aldaz,
E.Schuster,
and
T.A.Baker
(1996).
The interwoven architecture of the Mu transposase couples DNA synapsis to catalysis.
|
| |
Cell,
85,
257-269.
|
 |
|
|
|
|
 |
H.Savilahti,
and
K.Mizuuchi
(1996).
Mu transpositional recombination: donor DNA cleavage and strand transfer in trans by the Mu transposase.
|
| |
Cell,
85,
271-280.
|
 |
|
|
|
|
 |
M.D.Andrake,
and
A.M.Skalka
(1996).
Retroviral integrase, putting the pieces together.
|
| |
J Biol Chem,
271,
19633-19636.
|
 |
|
|
|
|
 |
P.Levy-Mintz,
L.Duan,
H.Zhang,
B.Hu,
G.Dornadula,
M.Zhu,
J.Kulkosky,
D.Bizub-Bender,
A.M.Skalka,
and
R.J.Pomerantz
(1996).
Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.
|
| |
J Virol,
70,
8821-8832.
|
 |
|
|
|
|
 |
P.Rice,
R.Craigie,
and
D.R.Davies
(1996).
Retroviral integrases and their cousins.
|
| |
Curr Opin Struct Biol,
6,
76-83.
|
 |
|
|
|
|
 |
R.Zheng,
T.M.Jenkins,
and
R.Craigie
(1996).
Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity.
|
| |
Proc Natl Acad Sci U S A,
93,
13659-13664.
|
 |
|
|
|
|
 |
M.D.Andrake,
and
A.M.Skalka
(1995).
Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase.
|
| |
J Biol Chem,
270,
29299-29306.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |